Ligutan, Shamcey A.
HRN: 23-48-60 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2026
CEFUROXIME 750MG (VIAL)
06/27/2026
07/04/2026
IV
750mg
Q 8
UTI
Checking Initial Appropriateness